BOARD ACTION: Board Approves Assistance to Meridian Clinical Research
For more information contact:
Kanan Kappelman, Iowa Economic Development Authority
IEDA Board approves assistance to Meridian Clinical Research
June 19, 2020 (DES MOINES, IA) – Today, the Iowa Economic Development Authority Board approved an award to Meridian Clinical Research. The company, headquartered in Omaha, Nebraska, plans to relocate its existing operations in Dakota Dunes, South Dakota to Sioux City.
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research vaccines, drugs, medical devices, therapies and diagnostics. Meridian is pursuing this relocation to a larger facility to service more clinical research trials, bring on additional specialized therapeutic areas for studies, create an on-site lab, and establish a new participant recruitment call center. The timing and scale of the relocation has been amplified by the anticipated operational demands accompanying COVID-19 vaccine trials.
The board awarded the company state tax benefits through the Targeted Jobs program. The project represents a $630,000 capital investment by Meridian and is also projected to create 35 jobs in Sioux City, of which six are incented at a qualifying wage threshold exceeding $20.55 per hour.
# # #
Download a spreadsheet with today's awards: